Radiation therapy is a major treatment modality for management of non-small cell lung
cancer. Radiation pneumonitis is a dose limiting toxicity of radiotherapy, affecting its …

Radiation-induced lung injury (RILI) is one of the main dose-limiting side effects in patients
with thoracic cancer during radiotherapy. No reliable predictors or accurate risk models are …

Background Patients with non-small cell lung cancer may develop pneumonitis after thoracic
radiotherapy (RT) and immune checkpoint inhibitors (ICIs). We hypothesized that distinct …

Abstract Background Stereotactic Ablative Radiotherapy (SABR) is the standard treatment
for early-stage medically inoperable lung cancer. Predictors of radiation pneumonitis (RP) in …

Over the last two decades, humans have encountered three substantial outbreaks of new
coronavirus (CoV) epidemics. The first, in the early 2000s, was caused by the severe acute …

Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage
non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients …

The release of a homogeneous high dose to the tumour region has been one of the
cornerstones of radiotherapy (RT) treatment since its early days. According to the organ type …

Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung
dosimetry - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Background Normal lung tissue tolerance constitutes a limiting factor in delivering the
required dose of radiotherapy to cure thoracic and chest wall malignancies. Radiation …

Purpose To apply a previously designed framework for predicting radiation pneumonitis by
using pretreatment lung function heterogeneity metrics, anatomic dosimetry, and functional …